(Q78336614)
Statements
The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer (English)
H Tsuda
Y Hashiguchi
S Nakata
M Deguchi
S Negoro
O Ishiko
1 September 2002